COMPOSITION

Each 1ml:

Flunixin (as meglumine) ……………………………………….………... 50 mg

Phenol ……………………………………………………………………. 5 mg

Sodium formaldehyde sulfoxylate …………………………………….. 2.5 mg

Excipient…………………………..qs…….……………….………………. 1 ml.

DOSAGE AND ADMINISTRATION

In Pigs:

- Mastitis-Metritis-Agalactia syndrome of the sow:

Route of administration: Intramuscular (IM).

Dosage: 2 mg of Flunixin per kg bodyweight and per day, equivalent to 2 ml of GENIXINE^® per 50 kg bodyweight, for 1 to 3 consecutive days.

- Alleviation of fever associated with respiratory diseases:

Route of administration: Intramuscular (IM).

Dosage: 2 mg of Flunixin per kg bodyweight and per day, equivalent to 2 ml of GENIXINE^® per 50 kg bodyweight, once time.

In Cattle:

Route of administration: Intramuscular (IM) or Intravenous (IV).

Dosage: 2 mg of Flunixin per kg bodyweight and per day, equivalent to 2 ml of GENIXINE^® per 50 kg bodyweight, for 1 to 5 consecutive days.

In the horses:

- Treatment of the inflammation and the alleviation of pain associated with musculo-skeletal disorders:

Route of administration: Intravenous (IV).

Dosage: 1 mg of Flunixin per kg bodyweight and per day, equivalent to 1 ml of GENIXINE^® per 50 kg bodyweight, for 1 to 5 consecutive days.

- Alleviation of visceral pain associated with colic:

Route of administration: Intravenous (IV).

Dosage: 1 mg of Flunixin per kg bodyweight and per day, equivalent to 1 ml of GENIXINE^® per 50 kg bodyweight. Treatment may be repeated once or twice if colic recurs.

RECOMMENDATIONS

The vial may be used 15 times at most and should be disposed of.

CONTRAINDICATION

Do not use in animals suffering from chronic musculosqueletal disorders.

Do not use in animals suffering from cardiac, hepatic or renal disease.

Do not use in animals with possible gastro-intestinal lesions (gastro-intestinal ulceration or bleeding).

Do not use in case of hemorrhagic disorders.

Do not use in case of hypersensitivity to flunixin meglumine, other NSAIDs or another component of the product.

Do not use in animals suffering from colic caused by ileus and associated with dehydration.

Do not use in cows within the 48 hours before the expected date of the parturition. An increase in stillbirth has been observed.

USE DURING PREGNANCY OR LACTATION

Studies in laboratory animals have produced evidence of foetotoxicity of flunixin after oral administration (rabbit and rat) and intramuscular administration (rat) at maternotoxic doses as well as an increase of the pregnancy period (rat).

Innocuity of flunixin was demonstrated in pregnant cows and sows, as well as boars. The product may be used in these species except within the 48 hours before birth.

The product should be used, within the 36 hours after parturition, only after benefit-risk assessment carried out by the responsible veterinarian. The risk of placental retention should be look after in treated animals.

OVERDOSE

Flunixin is a non-steroidal anti-inflammatory drug.

Overdosage is associated with gastrointestinal toxicity.

Ataxia and incoordination symptoms may also appear.

In the horse, from 3 fold the recommended dose (3 mg/kg bodyweight) administered by intravenous injection, a transient increase of the blood pressure may be observed.

In cattle, administration of 3 fold the recommended dose (6 mg/kg bodyweight) by intravenous injection did not induce untoward effects.

In pigs, from 2 mg/kg, administered by intramuscular injection, a transient painful reaction and an increase of leucocytes number may occur at the injection site.

WITHDRAWAL PERIOD

Meat and offal:

– Pigs: 20 days

– Cattle: 10 day

– Horses: 10 day

Milk:

– Cattle: 0 day

– Horses: Do not use in milking mares when milk is used for human consumption.

PRESENTATION

Bottle (50; 100 ml).

STORAGE

Keep out of the reach and sight of children.

Once broached, do not store above a temperature of 25°C and use by 28 days.

FOR ANIMAL TREATMENT ONLY

If you need more detailed information, please do not hesitate to contact us or send us an e-mail to contact.vn@ceva.com!